ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
American College of Cardiology
The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted ...
How Low and How Fast Should We Go with LDL Cholesterol?
A personalized approach to lowering cholesterol is crucial in preventing heart attacks, as the optimal level, speed, and duration of low-density lipoprotein (LDL) reduction can vary from person to person. Both physicians and patients must carefully assess and monitor these factors to achieve the best cardiovascular outcomes. In this interview, Drs. Douglas Weaver and Kausik Ray delve into the importance of individualized cholesterol management. They discuss the latest research, the benefits of aggressive LDL reduction, and how tailoring treatment plans can help optimize heart health while minimizing risks. Subscribe on Apple Podcasts | Subscribe to ACCEL
--------
14:10
Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs To Improve Statin Rates
Notifying patients and their clinicians about incidental coronary calcium findings can encourage shared decision-making on preventive therapies and significantly boost statin use among high-risk individuals. Each year, tens of millions of chest computed tomography (CT) scans are performed, yet valuable data on coronary calcium often remain unused — an untapped opportunity to enhance cardiovascular prevention. In this interview, Drs. Glenn Hirsch and Alexander Sandhu discuss how screening previously acquired non-gated chest CTs can help improve statin prescription rates and optimize preventive care. Subscribe on Apple Podcasts | Subscribe to ACCEL
--------
10:25
Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the RV and Treatment Target
Pulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomized clinical trial results and explored novel strategies to enhance patient outcomes. Their findings uncovered key data essential for improving clinical care. In this interview, Drs. William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease. Subscribe on Apple Podcasts | Subscribe to ACCEL
--------
11:59
Cardiovascular Health, CKM Syndrome and CVD Risk: Putting It All Together
Three complementary constructs ̶ cardiovascular health, cardiovascular-kidney-metabolic (CKM) syndrome, and cardiovascular disease (CVD) risk assessment ̶ exist to aid physicians in understanding where a patient is in the journey from health to disease and assist with clinical decision-making for preventive interventions across the life course. In this interview, Drs. Clyde Yancy and Donald Lloyd-Jones review the origins, objectives, and application of these cardiovascular constructs in practice. SUGGESTED MATERIALS: 1. Lloyd-Jones DM, Allen NB, Anderson CAM, et al; on behalf of the American Heart Association. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation 2022;146:e18-e43. 2. Ndumele CE, Rangaswami J, Chow SL, et al; on behalf of the American Heart Association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 2023;148:1606-35. 3. Khan SS, Matsushita K, Sang Y, et al; for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association’s PREVENT equations. Circulation 2023;149:430-49. Subscribe on Apple Podcasts | Subscribe to ACCEL
--------
15:11
Artificial Intelligence-based Automated ECHOcardiographic Measurements and the Workflow of Sonographers (AI-ECHO): Randomized Crossover Trial
The use of artificial intelligence (AI) assistance in echocardiography is proving beneficial in a multitude of ways: significantly reducing time per examination, increasing the average number of examinations per day, improving image quality, and decreasing mental fatigue in sonographers. Through AI-based echocardiography patients receive faster, high-quality diagnostics, which benefit both patient care and clinician workflow. In this interview, Drs. Jeroen Bax and Nobuyuki Kagiyama examine the results of the AI-ECHO randomized crossover trial. Subscribe on Apple Podcasts | Subscribe to ACCEL
About ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.
Listen to ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research, On Purpose with Jay Shetty and many other podcasts from around the world with the radio.net app
South Africa